Journal article Open Access

Not Tripping over TRIPS: An Analysis of Necessity and Legality of the COVID-19 TRIPS Waiver Proposal

Ahan Gadkari; Sofia Dash


Citation Style Language JSON Export

{
  "DOI": "10.35940/ijrte.E6675.011052", 
  "container_title": "International Journal of Recent Technology and Engineering (IJRTE)", 
  "language": "eng", 
  "title": "Not Tripping over TRIPS: An Analysis of  Necessity and Legality of the COVID-19 TRIPS  Waiver Proposal", 
  "issued": {
    "date-parts": [
      [
        2022, 
        1, 
        30
      ]
    ]
  }, 
  "abstract": "<p>The availability of vaccinations against COVID-19 provides hope for containing the epidemic, which has already claimed over 2.84 million lives. However, inoculating millions of individuals worldwide would need large vaccine manufacturing followed by fair distribution. A barrier to vaccine development and dissemination is the developers&#39; intellectual property rights. India and South Africa have jointly sought to the World Trade Organization that certain TRIPS rules of COVID-19 vaccines, medicines, and treatments be waived. This piece argues for such a waiver, highlighting the unique circumstances that exist. It believes that TRIPS&#39;s flexibilities are inadequate to cope with the present epidemic, particularly for nations without pharmaceutical manufacturing competence.</p>", 
  "author": [
    {
      "family": "Ahan Gadkari"
    }, 
    {
      "family": "Sofia Dash"
    }
  ], 
  "page": "61-65", 
  "volume": "10", 
  "type": "article-journal", 
  "issue": "5", 
  "id": "5804101"
}
40
23
views
downloads
Views 40
Downloads 23
Data volume 6.5 MB
Unique views 35
Unique downloads 23

Share

Cite as